PT-141 side effects usually include nausea, flushing, and headache, but blood pressure changes and hyperpigmentation can occur too. Here's what to know.
The most common PT-141 side effects are nausea, flushing, and headache, and they appear in a large share of people who use the drug in clinical trials. Bremelanotide (PT-141) can also cause injection-site reactions and a temporary rise in blood pressure. Most reactions are mild to moderate and ease within a few hours, but blood pressure shifts and skin darkening with repeated dosing are worth discussing with a healthcare professional before you start.
What PT-141 Is and Who It Is Approved For
PT-141 is the research name for bremelanotide, a melanocortin receptor agonist that works on the central nervous system rather than on blood flow. The FDA approved it in 2019 as Vyleesi, a subcutaneous injection for premenopausal women with hypoactive sexual desire disorder (HSDD).
It is not approved for men, for postmenopausal women, or for general sexual enhancement. Because the FDA label is built on trials in premenopausal women, the pt-141 for women side effects profile is the best documented in the medical literature. Men who use it typically do so off-label or through research chemical suppliers, where dosing and purity are not regulated.
Most Common PT-141 Side Effects
In the Phase 3 trials that supported approval, roughly 40% of participants reported nausea at the 1.75 mg injected dose. Flushing, injection-site reactions, and headache were the next most frequent complaints.
| Side effect | Approximate frequency (1.75 mg injection) | When it usually starts |
|---|---|---|
| Nausea | About 40% | Within 1 hour, eases over a few hours |
| Flushing | About 20% | 15 to 60 minutes after dosing |
| Injection-site reaction | About 13% | First 24 hours |
| Headache | About 11% | 1 to 3 hours |
| Vomiting | About 5% | 1 to 2 hours |
| Dizziness, tingling, sweating | Less common (under 5%) | Within a few hours |
These figures come from trials of the injected dose, and the side effects of pt 141 generally follow a similar pattern at other doses. Most of what circulates online about pt-141 peptide side effects comes from small studies and user reports rather than from large controlled trials.
Nausea and Vomiting
Nausea is the single most reported reaction, and it is the main reason some users stop treatment. It usually peaks within the first hour and fades over several hours.
Vomiting is far less common than nausea but more disruptive when it happens. Taking the dose on a lighter stomach, or at a time when you can rest, may reduce how much it interferes with your day.
Flushing, Headache, and Injection-Site Reactions
Flushing feels like warmth in the face, neck, or chest and typically resolves on its own. Headaches tend to be mild to moderate and respond to standard over-the-counter pain relief for most people.
Injection-site reactions include pain, bruising, itching, and small bumps. Rotating injection sites and avoiding areas that are irritated can lower the odds of a reaction.
Blood Pressure and Cardiovascular Effects
Bremelanotide can cause a short-term increase in blood pressure, usually within the first few hours after a dose. In trials, average systolic and diastolic readings rose modestly, and some participants had elevations large enough to matter clinically.
PT-141 is contraindicated in people with uncontrolled hypertension or known cardiovascular disease. The FDA also required a post-approval cardiovascular safety study to better characterize longer-term risk. If you take blood pressure medication or have any heart condition, talk with a clinician before using PT-141.
Skin Darkening With Repeated Use
Focal hyperpigmentation, meaning dark patches on the skin, gums, or other mucosal surfaces, has been reported with repeated PT-141 use. The label limits dosing to no more than one dose in 24 hours and no more than eight doses per month specifically to reduce this risk.
In postmarketing reports, some users noticed darkening after multiple doses, and the effect did not always reverse after stopping the drug. People with darker skin tones may be more susceptible. Report any new or spreading dark patches to a healthcare professional promptly.
PT-141 for Men and Nasal Spray Products
PT-141 is not FDA-approved for men. Early studies of an intranasal formulation in men with erectile dysfunction showed modest benefits alongside high rates of nausea, and current interest centers on off-label use. Data on pt-141 side effects men experience come mostly from those older trials, small studies, and user reports, so the true risk profile in men is less certain than in women.
Nasal sprays sold by research chemical vendors are not approved for human use, are not made in licensed pharmacies, and may contain impurities or inaccurate concentrations. Reports of pt-141 peptide nasal spray side effects describe the same cluster of nausea, flushing, headache, and nasal irritation, but dosing is harder to control than with an injection.
How to Lower Your Risk of Side Effects
- Follow the labeled dose of 1.75 mg, no more than once in 24 hours and no more than eight times per month.
- Inject into the abdomen or thigh and rotate sites to limit irritation.
- Ask a clinician whether meals or timing affect your nausea.
- Get blood pressure checked before starting, especially if you have a history of hypertension.
- Avoid combining PT-141 with other vasoactive drugs unless a clinician approves it.
- Buy only from a licensed pharmacy with a valid prescription, never from unverified peptide sellers.
- Report severe headache, chest symptoms, or new skin darkening right away.
PT-141 side effects are common but usually manageable, and most people who continue treatment do so without serious problems. The key is matching the drug to the right patient and monitoring blood pressure and skin changes over time. This information is educational and is not a substitute for personalized medical advice.
Frequently Asked Questions
What are the most common side effects of PT-141?
In clinical trials of the 1.75 mg injection, nausea was reported by about 40% of participants, followed by flushing at roughly 20%, injection-site reactions at about 13%, and headache at about 11%. Vomiting, dizziness, tingling, and sweating occur less often. Most reactions are mild to moderate and ease within a few hours.
How long do PT-141 side effects last?
Nausea and flushing typically begin within an hour of the injection and ease within a few hours, often by the four- to six-hour mark. Headaches can linger a bit longer, and injection-site reactions may last a day or two. Focal hyperpigmentation, when it occurs, can persist and may not fully reverse after stopping the drug.
Can PT-141 raise blood pressure?
Yes. Bremelanotide can cause a short-term rise in blood pressure, usually in the first few hours after a dose, which is why it carries a contraindication for people with uncontrolled hypertension or known cardiovascular disease. Anyone with a heart or blood pressure condition should speak with a clinician before using it.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.